EN
HI

VENUS REMEDIES Share price

VENUSREM

HealthcareSmall

355.6

0.55 (0.15%)
NSE
BSE
Last updated on 23 May, 2025 | 15:55 IST
BUYSELL
Today's High

361.25

Today's Low

351.10

52 Week Low

270.25

52 Week High

427.90

The current prices are delayed, login to your account for live prices

Venus Remedies Chart

VENUS REMEDIES Fundamentals

P/E Ratio

13.62

P/B Ratio

0.92

Div. Yield

0

Sector P/E

30.11

Sector P/B

3.8

Sec. Div. Yield

0.52

VENUS REMEDIES Resistance and Support

Pivot 355.33

Resistance

First Resistance

361.66

Second Resistance

368.28

Third Resistance

374.61

Support

First Support

348.71

Second Support

342.38

Third Support

335.76

VENUS REMEDIES Futures & Options

Data Not Found

VENUS REMEDIES Shareholding Pattern

    Total Promoters
    Segment
    Percent

    Total Promoters

    41.76%

    Mutual Fund

    0%

    Insurance

    0%

    Foreign Institutional Investors

    1.34%

    Domestic Institutional Investors

    0%

    Retail

    56.9%

    Others

    0%

    Total Promoters
    MAR '25
    41.76%

    VENUS REMEDIES Corporate Actions

    DateAgenda
    2025-05-26Audited Results
    2025-02-04Quarterly Results
    DateEvent TypeAgenda
    2025-05-26Board MeetingAudited Results
    2025-02-04Board MeetingQuarterly Results

    VENUS REMEDIES News

    Venus Remedies gets GMP approval for pre-filled syringe facility

    Nov 05 2024 15:21:59
    Read More

    About VENUS REMEDIES AboutThe

    NSE : 13859  
    BSE : 526953  
    ISIN : INE411B01019  

    M/s VENUS REMEDIES LTD. was incorporated as a privatelimited company on 15th day of Sept. 1989 in the name andstyle of Venus Glucose Pvt Ltd and subsequently convertedinto a public limited company vide fresh certificate ofincorporation dated 19th Sept. 1994 and the name wasconverted as "Venus Remedies Ltd" under the Companies Actissued by the Registrar of Companies Punjab HimachalPradesh and Chandigarh at Jalandhar. The company startedits production in the year 1991 withIntravenous/Intramuscular (IV/IM) injectable forms at itsrunning unit located at 52 Ind. Area. Phase-I PanchkulaDistt. Ambala (Haryana). Subsequently the companyintroduced Eye/Ear/Nasal Drops during the year 1994. Duringthe same year the company also expanded its existingcapacity from 9 lacs pieces per annum to 15 lacs pieces perannum and that of 9 lacs pieces to 20 lacs pieces per annumof IV fluids section and vial section respectively. Andduring 1994 the company has also certified as "WHO-GMP"(Good practices in manufacturing and quality control) asspecified by WHO Geneva by the State Drug Controller ofHaryana.MAIN OBJECTS OF THE COMPANYThe main objects of the company as set out in itsMemorandum of Association are :1. To manufacture import export of intravenous transfusionfluids and formations such as dextrose dextrose withsodium chloride normal saline isolate P isolate Misolate G isolate E Mannitol etc. in variousconcentrations intravenous solution for dialysis purposesACD Sterile bottles for blood collections pharmaceuticalparenteral preparations like AminophyllineAdernaline Water for injection Chloroquine SulphateSodium bi-carbonate Analgin Diazepam Oxyphenbutazone &other injectables.2. To carry on the business of deriving formulatingpurchasing producing manufacturing preparing processingmising compounding refining marketing distributingselling and trading in pharmaceuticals Chemicalscosmetics perfumes medicines and drugs of all kindsspecifications and descriptions and to do so especially inrespect of all kinds of analgesics and antipyretics.3. To carry on the business of purchasing producingmanufacturing preparing processing mixing compoundingrefining marketing distributing selling and trading inall classes and kinds of raw material ingredientsmixtures compounds and derivatives connected tointermediate in or associated with the manufactureproduction and sale of pharmaceuticals chemicals medicinesand drugs.4. To carry on the business of vialling bottling packing.repacking and processing of capsules syrups tabletsinjectables aerosoles and ointment bulk drugs andchemicals.

    VENUS REMEDIES Management

    NamePosition
    Mr. Pawan Chaudhary Chairman & Managing Director
    Dr.(Mrs.) Manu Chaudhary Joint Managing Director
    Mr. Peeyush Jain Deputy Managing Director
    Mr. Ashutosh Jain Executive Director
    Mr. Akshansh Chaudhary Executive Director
    Read More

    VENUS REMEDIES FAQs

    VENUS REMEDIES शेयर का खरीद मूल्य 355.6 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

    VENUS REMEDIES शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

    VENUS REMEDIES शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 13.62 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

    VENUS REMEDIES शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 0.92 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

    VENUS REMEDIES शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.8 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

    VENUS REMEDIES का मार्केट कैप 475.33 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

    VENUS REMEDIES शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 427.90 और 270.25 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

    VENUS REMEDIES Share Key Metrics

    Volume
    22355.00
    Market Cap
    475.33 CR
    LTQ@LTP
    24@355.60
    ATP
    356.49
    Var Margin
    23.64 %
    Circuit Range
    284.05-426.05
    Delivery %
    52.77 %
    Value
    79.69 L
    ASM/GSM
    No
    Market Lot
    1